SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8955Great quarter, should turn profitable q4 or q1. +3 premarket.rkrw-10/25/2005
8954And here's the release for those who want it here: I didn't see any Q4 quidditch-10/25/2005
8953Sepracor results out at breakeven with the gain on stock sale and a loss of 19 cRobohogs-10/25/2005
8952I think the trade-off between revenue and expense, particularly advertising expequidditch-10/24/2005
8951OK, thanks for the lesson in DTC advertising restrictions; I'll get over it,tuck-10/24/2005
8950<i>No mention of what Lunesta is actually for, which would have taken one Biomaven-10/24/2005
8949You could be right about the pps drifting down - or it could go up. I am no expHarold Engstrom-10/24/2005
8948I wasn't disputing Jon's analysis of the sales numbers at all. I've bearofbleecker-10/24/2005
8947Too bad they didn't do something more useful like compare to lunesta.rkrw-10/24/2005
8946Driving Study Preliminary Results (from NBIX Q3 report]. Neurocrine recently coIcebrg-10/24/2005
8945Posts like the one I am responding to really surprise me here at SI. The evidHarold Engstrom-10/24/2005
8944On the basis of what I've seen, I'd guess that they've dramatically bearofbleecker-10/24/2005
8943<i>who recently went long circa $52.90</i> Timed that one nicely!FiloF-10/24/2005
8942GS' take on the numbers for the sleep segment: <<Recent prescription quidditch-10/24/2005
8941Been awfully cold here in New England. Xopenex rx should start picking up soon. rkrw-10/24/2005
8940I think they will miss Xopenex estimates for Q3 and guide down on Xopenex for Q4Robohogs-10/24/2005
8939"Q3 Earnings will be interesting 10/25/05. -.61eps at 165M revenue. I wouldRocky9-10/24/2005
8938I was watching the World Series last night and saw the Lunesta ad left of home ptuck-10/24/2005
8937Trade offs. Costs of sales is exceeding the sales revenue! These other guys yodavid nordic-10/24/2005
8936David, 1.5% weekly growth equates to 100% annual growth. Scrip levels are off Robohogs-10/24/2005
8935TV is saturated with ads and I would expect sales to be up big time, not happenidavid nordic-10/24/2005
8934Quick report on scripts: Xopenex continues very weak (flat week over week) - wiRobohogs-10/24/2005
8933What happened? Unreadable? Shucks!! JonRobohogs-10/20/2005
8932Anyone else notice the lunesta ad behind home plate tonight? I can barely read irkrw-10/19/2005
8931If it's not meridia what is it? CNS focus won't be easy or cheap.rkrw-10/19/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News